Revenue
2018
2019
2020
2021
2022
2023
2024
2025
Viemed Healthcare, Inc. (VMD)
Price$8.95Cached quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $270.3M | $224.3M | $183.0M | $138.8M | $117.1M | $131.3M | $80.3M | $64.5M |
| Gross profit | $155.5M | $133.2M | $112.8M | $84.7M | $73.4M | $80.1M | $56.0M | $47.8M |
| Gross margin | 57.52% | 59.40% | 61.63% | 60.99% | 62.71% | 61.01% | 69.78% | 74.11% |
| Research & development | $3.0M | $3.1M | $2.8M | $2.7M | $2.1M | $1.1M | $848,000 | $0 |
| Operating expenses | $132.5M | $115.3M | $98.5M | $76.4M | $61.8M | $53.3M | $47.1M | $37.7M |
| Operating income | $22.9M | $17.9M | $14.3M | $8.3M | $11.6M | $26.8M | $8.9M | $10.1M |
| Operating margin | 8.49% | 7.98% | 7.83% | 5.94% | 9.89% | 20.40% | 11.04% | 15.60% |
| EBITDA | $51.6M | $43.3M | $36.2M | $23.9M | $22.9M | $36.4M | $15.3M | $13.8M |
| EBITDA margin | 19.08% | 19.29% | 19.78% | 17.20% | 19.56% | 27.69% | 19.01% | 21.47% |
| Net income | $14.9M | $11.3M | $10.2M | $6.2M | $9.1M | $31.5M | $8.5M | $9.5M |
| Net profit margin | 5.53% | 5.02% | 5.60% | 4.48% | 7.80% | 24.01% | 10.62% | 14.75% |
| Basic EPSper basic share | $0.38 | $0.29 | $0.27 | $0.16 | $0.23 | $0.81 | $0.23 | $0.25 |
| Diluted EPSper diluted share | $0.37 | $0.28 | $0.25 | $0.16 | $0.22 | $0.78 | $0.21 | $0.24 |
Owners
Reported shareholders
12.57%of listed shares
BlackRock, Inc.4.79M shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
BlackRock, Inc. | 12.57%4.79M shares |
Hoyt Casey | ≈6.13%2.34M shares |
Forager Capital Management, LLC | 5.62%2.14M shares |
Moore Michael | ≈4.66%1.77M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 3.47%1.32M shares |
Nantahala Capital Management, LLC | 3.32%1.26M shares |
GOLDMAN SACHS GROUP INC | 3.21%1.22M shares |
First Eagle Investment Management, LLC | 2.81%1.07M shares |
AMERIPRISE FINANCIAL INC | 2.64%1.01M shares |
GEODE CAPITAL MANAGEMENT, LLC | 2.56%973.74K shares |
RAFFLES ASSOCIATES LP | 2.12%807.38K shares |
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 2.06%786.27K shares |
STATE STREET CORP | 2.00%762.1K shares |
PANAGORA ASSET MANAGEMENT INC | 1.41%538.63K shares |
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1.40%533.47K shares |
TWO SIGMA INVESTMENTS, LP | 1.15%438.85K shares |
RENAISSANCE TECHNOLOGIES LLC | 1.12%425.9K shares |
ACADIAN ASSET MANAGEMENT LLC | 1.05%398.59K shares |
ZEHNDER WILLIAM TODD | ≈1.02%390.31K shares |
Creative Planning | 0.95%360.36K shares |
Percentages use 38.09M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 25, 2026Form 4 | Frazier WilliamChief Medical Officer | SellCommon Shares | 10.0K | $11.72 | $117.2K | 73.2K |
| Jun 24, 2026Form 4 | Smokoff TimothyDirector | SellCommon Shares | 5.0K | $11.41 | $57.0K | 75.5K |
| Jun 24, 2026Form 4 | Smokoff TimothyDirector | SellCommon Shares | 5.0K | $11.53 | $57.6K | 80.5K |
| Jun 24, 2026Form 4 | Smokoff TimothyDirector | SellCommon Shares | 5.0K | $11.56 | $57.8K | 85.5K |
| Jun 24, 2026Form 4 | Smokoff TimothyDirector | SellCommon Shares | 3.4K | $11.50 | $38.7K | 90.5K |